When was Pfizer founded?

Pfizer was founded in 1849 and raised its 1st funding round 160 years after it was founded.

Where is Pfizer located?

Pfizer is headquartered in New York City, United States. It is registered at Peapack, New Jersey.

Which legal entities is Pfizer associated with?

Pfizer is associated with PFIZER LIMITED and 10 others.

How many employees does Pfizer have?

As of Mar 31, 2026, the latest employee count at Pfizer is 102894.

Is Pfizer a funded company?

Pfizer is a funded company, having raised an undisclosed amount across 11 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Jun 02, 2009.

When was the latest funding round of Pfizer?

Pfizer's latest funding was a $***** Grant (prize money) round on Jun 27, 2023, with participation from 1 investor.

What is the annual revenue of Pfizer?

Annual revenue of Pfizer is $62.6B as on Dec 31, 2025.

Where does Pfizer rank among its competitors?

Pfizer ranks 7th amongst 1106 active competitors, of which 70 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Johnson & Johnson, which secured $34M in Feb, 2025.

Who are the top competitors of Pfizer?

Pfizer's top competitors include AbbVie, Amgen and Gilead. Among them, Johnson & Johnson secured the most recent funding round in February, 2025.

Pfizer - 2026 Company Profile, Team, Funding, Competitors & Financials

Pfizer is a public company based in New York City (United States), founded in 1849 by Charles Pfizer and Charles Erhart. It operates as a Provider of pharmaceutical products for multiple disease treatments. Pfizer has raised an undisclosed amount in funding. The company has 1106 active competitors, including 70 funded and 171 that have exited. Its top competitors include companies like AbbVie, Amgen and Gilead.

Company Details

Provider of pharmaceutical products for multiple disease treatments. It has developed a novel cancer medicine that works by inhibiting blood supply in tumor cells and destroys cellular reproduction. The other product includes Chantix that helps smokers to quit smoking.In 2022, the company recorded annual revenues of $92.95B and a net profit of $29.04B.

Website: www.pfizer.com/
Social
Phone Number: +1 **********
Registered Address: Peapack, New Jersey

Key Metrics

Founded Year

1849

Location

New York City, United States

Stage

Public

Latest Funding Round

Grant (prize money), Jun 27, 2023, $*****

Investors

Alcor Fund & 17 more

Ranked

7^th among 1106 active competitors

Annual Revenue

$62.6B as on Dec 31, 2025

Employee Count

102,894 as on Mar 31, 2026

Investment & Acquisitions

Storm Therapeutics & 199 more

Similar Companies

AbbVie & 2557 more

Exit Details

Public

View Pfizer's full profile

Pfizer is associated with 11 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PFIZER LIMITED CIN: L24231MH1950PLC008311 , India, Active	Nov 21, 1950	$290M (As on Mar 31, 2025)	1711 (As on Feb 29, 2024)
PFIZER INC CIN: 0713.748.368 , Belgium, Active	Aug 01, 2018	$63.3B (As on Dec 31, 2023)	-	-
Pfizer Inc CIN: 135315170 , United States, Active	Dec 26, 999	$62.6B (As on Dec 31, 2025)	29469 (As on Dec 31, 2024)	-
PFIZER PRODUCTS INDIA PRIVATE LIMITED CIN: U24230MH1996FTC148003 , India, Active	Dec 19, 1996	$85.6M (As on Mar 31, 2025)	399 (As on Aug 01, 2025)
WATSON PHARMA PRIVATE LIMITED CIN: U24230MH2005PTC156968 , India, Active	Oct 21, 2005	$121M (As on Mar 31, 2025)	1035 (As on Mar 31, 2024)
Trillium Therapeutics Inc. CIN: 1616212 , United States, Active	Mar 25, 2015	$148K (As on Dec 31, 2020)	-	-
PFIZER HEALTHCARE INDIA PRIVATE LIMITED CIN: U24232TN2009PTC073563 , India, Active	Nov 17, 2009	$234M (As on Mar 31, 2025)	2457 (As on Feb 29, 2024)
Pfizer Export B.V. CIN: 26397472429 , Croatia, Active	Jun 26, 2017	$5.89M (As on Nov 30, 2018)	-
PFIZER PHARMACEUTICALS LLC CIN: 660577291 , United States, Active	Dec 31, 1999	-	1362 (As on Dec 31, 2024)	-
PFIZER (THAILAND) COMPANY LIMITED CIN: 0105511004048 , Thailand, Active	Aug 16, 1968	$128M (As on Dec 31, 2023)	-
PFIZER AS CIN: 915213596 , Norway, Active	Nov 24, 1959	-	108 (As on Dec 31, 2022)

Pfizer got listed on Dec 21, 1984.

Click here to take a look at Pfizer's IPO in detail

Pfizer has raised funding over 11 rounds. Its first funding round was on Jun 02, 2009. Its latest funding round was a Grant (prize money) round on Jun 27, 2023 for $*****. 1 investor participated in its latest round. Pfizer has 18 institutional investors.

Here is the list of recent funding rounds of Pfizer:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 27, 2023	2952945	Grant (prize money)	3348287	8230193	2057126	3930851
Jan 01, 2020	5406701	Grant (prize money)	7021806	4054510	7600928	Europa
Sep 2018	5816042	Conventional Debt	9289348	7673379	6292762	3807967

Access funding benchmarks and valuations. Sign up today!

View details of Pfizer's funding rounds and investors

The founders of Pfizer are Charles Pfizer and Charles Erhart.

Here are the details of Pfizer's key team members:

Charles Pfizer: Former Co-Founder of Pfizer and founder of 1 other company.
Charles Erhart: Former Co-Founder of Pfizer and founder of 1 other company.
Albert Bourla: CEO of Pfizer.

View details of Pfizer's Founder profiles and Board Members

Pfizer's employee count trend

Pfizer has 102,894 employees as of Mar 26. Here is Pfizer's employee count trend over the years:

Uncover Pfizer's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pfizer include AbbVie, Amgen and Gilead. Here is the list of Top 10 competitors of Pfizer, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Alcor Fund, Black Capital Investments & 8 others	81/100
2nd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Amgen Business Development, Digital Pharma Lab ... & 11 others	81/100
3rd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	Aisling Capital, BB Biotech & 17 others	81/100
4th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	80/100
5th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Alcor Fund, 27th Street Capital & 16 others	78/100
6th	Juno Therapeutics 2013, Seattle (United States), Acquired	Global biopharmaceutical company discovering, developing, and delivering innovative medicines	$317M	RA Capital Management, BB Biotech & 14 others	74/100
7th	Pfizer 1849, New York City (United States), Public	Provider of pharmaceutical products for multiple disease treatments	-	Alcor Fund, Benson Family Private Equity ... & 16 others	73/100
8th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 7 others	71/100
9th	Novartis 1996, Basel (Switzerland), Public	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, MT Capital & 9 others	70/100
10th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	SoftBank Group, Triodos Investment Management ... & 10 others	70/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Pfizer's competitors? Click here to see the top ones

Pfizer has made 161 investments in companies including Storm Therapeutics and Crossbow. Pfizer has also acquired 39 companies including Metsera and Seegene Technologies.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Apr 16, 2026	Investments	Storm Therapeutics	2015	Cambridge (United Kingdom)
Mar 18, 2026	Investments	Crossbow	2021	Cambridge (United States)
Jan 08, 2026	Investments	Enodia Therapeutics	2025	Paris (France)